Log In
person
Chugai Pharmaceutical Co Ltd
CHGCY
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2020
| Reporting Segmentarrow_drop_up | Product Line | Amount (JPY) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (JPY) | Percentage |
| Royalties and Other Operating Income |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
153.63B | 19.52% |
| Sales |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
633.31B | 80.48% |
| keyboard_arrow_down |
Royalties and Other Operating Income
Pharmaceutical Patent Licensing
|
153.63B | 19.52% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Sales
Branded Pharmaceuticals
|
633.31B | 80.48% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||